title: Benefits of ticagrelor debated as antiplatelet class approaches generic market.
authors: Value-based health department at Genentech. TMorrow@ManagedCareMag.com
authors: Thomas
authors: T
authors: Morrow
mesh_terms: D054058:Acute Coronary Syndrome / Q000188:drug therapy; D000241:Adenosine / Q000031:analogs & derivatives* / Q000191:economics / Q000494:pharmacology; D016568:Drugs, Generic / Q000191:economics; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000191:economics / Q000494:pharmacology; D000077486:Ticagrelor; D014481:United States
chemical_list: D016568:Drugs, Generic; D010975:Platelet Aggregation Inhibitors; D000077486:Ticagrelor; D000241:Adenosine